ST elevation myocardial infarction discharge care: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
/* Noninvasive Testing for Ischemia Before Discharge (DO NOT EDIT){{cite journal |author=O'Gara PT, Kushner FG, Ascheim DD,et al. |title=2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report ... |
||
| Line 20: | Line 20: | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Noninvasive testing for ischemia should be performed before discharge to assess the presence and extent of inducible ischemia in patients with STEMI who have not had coronary angiography and do not have high-risk clinical features for which coronary angiography would be warranted.<ref name="pmid460322">{{cite journal |author=Théroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala HF |title=Prognostic value of exercise testing soon after myocardial infarction |journal=N. Engl. J. Med. |volume=301 |issue=7 |pages=341–5 |year=1979 |month=August |pmid=460322 |doi=10.1056/NEJM197908163010701 |url=}}</ref><ref name="pmid7658777">{{cite journal |author=Villella A, Maggioni AP, Villella M, ''et al.'' |title=Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto |journal=Lancet |volume=346 |issue=8974 |pages=523–9 |year=1995 |month=August |pmid=7658777 |doi= |url=}}</ref><ref name="pmid6708976">{{cite journal |author=Leppo JA, O'Brien J, Rothendler JA, Getchell JD, Lee VW |title=Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction |journal=N. Engl. J. Med. |volume=310 |issue=16 |pages=1014–8 |year=1984 |month=April |pmid=6708976 |doi=10.1056/NEJM198404193101603 |url=}}</ref>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
Noninvasive testing for ischemia should be performed | |||
before discharge to assess the presence and | |||
extent of inducible ischemia in patients with STEMI | |||
who have not had coronary angiography and do not | |||
have high-risk clinical features for which coronary | |||
angiography would be warranted. | |||
<ref name="pmid460322">{{cite journal |author=Théroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala HF |title=Prognostic value of exercise testing soon after myocardial infarction |journal=N. Engl. J. Med. |volume=301 |issue=7 |pages=341–5 |year=1979 |month=August |pmid=460322 |doi=10.1056/NEJM197908163010701 |url=}}</ref><ref name="pmid7658777">{{cite journal |author=Villella A, Maggioni AP, Villella M, ''et al.'' |title=Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto |journal=Lancet |volume=346 |issue=8974 |pages=523–9 |year=1995 |month=August |pmid=7658777 |doi= |url=}}</ref><ref name="pmid6708976">{{cite journal |author=Leppo JA, O'Brien J, Rothendler JA, Getchell JD, Lee VW |title=Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction |journal=N. Engl. J. Med. |volume=310 |issue=16 |pages=1014–8 |year=1984 |month=April |pmid=6708976 |doi=10.1056/NEJM198404193101603 |url=}}</ref>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |||
|} | |} | ||
Revision as of 02:03, 28 December 2012
|
ST Elevation Myocardial Infarction Microchapters |
|
Differentiating ST elevation myocardial infarction from other Diseases |
|
Diagnosis |
|
Treatment |
|
|
Case Studies |
|
ST elevation myocardial infarction discharge care On the Web |
|
ST elevation myocardial infarction discharge care in the news |
|
Directions to Hospitals Treating ST elevation myocardial infarction |
|
Risk calculators and risk factors for ST elevation myocardial infarction discharge care |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2013 Revised ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarction (DO NOT EDIT)[1]
Implantable Cardioverter-Defibrillator Therapy Before Discharge (DO NOT EDIT)[1]
| Class I |
| "1. Implantable cardioverter-defibrillator therapy is indicated before discharge in patients who develop sustained ventricular tachycardia/ventricular fibrillation more than 48 hours after STEMI, provided the arrhythmia is not due to transient or reversible ischemia, reinfarction, or metabolic abnormalities.[2][3][4](Level of Evidence: B)" |
Noninvasive Testing for Ischemia Before Discharge (DO NOT EDIT)[1]
| Class I |
| "1. Noninvasive testing for ischemia should be performed before discharge to assess the presence and extent of inducible ischemia in patients with STEMI who have not had coronary angiography and do not have high-risk clinical features for which coronary angiography would be warranted.[5][6][7](Level of Evidence: B)" |
Sources
- 2013 Revised ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarction (DO NOT EDIT)[1]
References
- ↑ 1.0 1.1 1.2 1.3 O'Gara PT, Kushner FG, Ascheim DD; et al. (2012). "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e3182742c84. PMID 23247303. Unknown parameter
|month=ignored (help) - ↑ Wever EF, Hauer RN, van Capelle FL; et al. (1995). "Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors". Circulation. 91 (8): 2195–203. PMID 7697849. Unknown parameter
|month=ignored (help) - ↑ Siebels J, Kuck KH (1994). "Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)". Am. Heart J. 127 (4 Pt 2): 1139–44. PMID 8160593. Unknown parameter
|month=ignored (help) - ↑ Connolly SJ, Hallstrom AP, Cappato R; et al. (2000). "Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study". Eur. Heart J. 21 (24): 2071–8. doi:10.1053/euhj.2000.2476. PMID 11102258. Unknown parameter
|month=ignored (help) - ↑ Théroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala HF (1979). "Prognostic value of exercise testing soon after myocardial infarction". N. Engl. J. Med. 301 (7): 341–5. doi:10.1056/NEJM197908163010701. PMID 460322. Unknown parameter
|month=ignored (help) - ↑ Villella A, Maggioni AP, Villella M; et al. (1995). "Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto". Lancet. 346 (8974): 523–9. PMID 7658777. Unknown parameter
|month=ignored (help) - ↑ Leppo JA, O'Brien J, Rothendler JA, Getchell JD, Lee VW (1984). "Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction". N. Engl. J. Med. 310 (16): 1014–8. doi:10.1056/NEJM198404193101603. PMID 6708976. Unknown parameter
|month=ignored (help)